Investigating cancer mechanisms and potential treatments for pancreatic and breast cancer

BLR&D Research Career Scientist Award Application

NIH-funded research Jesse Brown VA Medical Center · NIH-11050910

This study is looking at how certain changes in our cells can lead to pancreatic and breast cancer, and it's working on creating new treatments that can help control these changes to fight the cancer better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJesse Brown VA Medical Center NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11050910 on NIH RePORTER

What this research studies

This research focuses on understanding the molecular mechanisms that lead to pancreatic and breast cancer. The team is exploring how certain cellular pathways become dysregulated, resulting in uncontrolled cell growth. They aim to develop small molecules that can target these dysregulated proteins to help mitigate the effects of these cancers. The research includes studying specific protein kinases and their inhibitors, which have shown promise in preclinical models.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with pancreatic or breast cancer, particularly those with Triple Negative breast cancer.

Not a fit: Patients with cancers unrelated to pancreatic or breast cancer may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new targeted therapies for pancreatic and breast cancer, potentially improving patient outcomes.

How similar studies have performed: Previous research has shown success in targeting similar pathways in cancer treatment, indicating a promising avenue for this approach.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer immunotherapy
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.